Vimarsana
Biggest News Aggregation in the World

Sarcoma Program Director News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarcoma Program Director. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarcoma Program Director Today - Breaking & Trending Today

Polaris Group Initiates Phase 3 Trial: First Patient Successfully Dosed with ADI-PEG 20/Placebo plus Gemcitabine and Docetaxel for Difficult-to-Treat Leiomyosarcoma (LMS) -December 04, 2023 at 07:02 am EST - Vimarsana News

Polaris Group Initiates Phase 3 Trial: First Patient Successfully Dosed with ADI-PEG 20/Placebo plus Gemcitabine and Docetaxel for Difficult-to-Treat Leiomyosarcoma (LMS) -December 04, 2023 at 07:02 am EST

Published: December 4, 2023

TAIPEI, Taiwan and SAN DIEGO, Dec. 04, 2023 -- Polaris Group , today announced that the first patient is successfully dosed in a pivotal Phase 3 trial that combines ADI-PEG 20 or placebo with...

Source: marketscreener.com
Related Topics:
T Ai PeiGina LeeWashington University In StSarcoma ProgramPolaris GroupCombo StrategySide EffectsBrian Van TineLead InvestigatorDirector Developmental TherapeuticsSarcoma Program DirectorWashington University
Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas - Vimarsana News

Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas

Published: August 4, 2022

HOUSTON, Aug. 04, 2022 -- Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options, announces the... | August 4, 2022

Source: marketscreener.com
Related Topics:
New YorkUnited StatesOregon Health Sciences UniversityMemorial Sloan Kettering Cancer CenterFox Chase Cancer CenterWashington UniversitySanta MonicaDana Farber Cancer InstituteSankt PeterburgLos AngelesDavid ArthurLee CranmerLarae DavisKim Sutton GolodetzSchool Of MedicineSalarius PharmaceuticalsUniversity Of Washington Medical CenterMd Anderson Cancer CenterSarcoma Program DirectorDivision Of Hematology Medical OncologySalarius Pharmaceuticals IncSeattle Cancer Care AllianceProduct Development AwardResearch Institute Of TexasGlobenewswire Inc